A fresh look at coronary microembolization

P Kleinbongard, G Heusch - Nature Reviews Cardiology, 2022 - nature.com
Mechanical stress from haemodynamic perturbations or interventional manipulation of
epicardial coronary atherosclerotic plaques with inflammatory destabilization can release …

Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine

S Khanra, P Reddy, A Giménez-Palomo… - Molecular …, 2023 - nature.com
Bipolar disorder's core feature is the pathological disturbances in mood, often accompanied
by disrupted thinking and behavior. Its complex and heterogeneous etiology implies that a …

Trimetazidine in heart failure

H Shu, Y Peng, W Hang, N Zhou… - Frontiers in …, 2021 - frontiersin.org
Heart failure is a systemic syndrome caused by multiple pathological factors. Current
treatments do not have satisfactory outcomes. Several basic studies have revealed the …

Cellular and molecular approaches to enhance myocardial recovery after myocardial infarction

Y Parviz, M Waleed, S Vijayan, D Adlam, S Lavi… - Cardiovascular …, 2019 - Elsevier
Reperfusion therapy has resulted in significant improvement in post-myocardial infarction
morbidity and mortality in over the last 4 decades. Nonetheless, it is well recognized that …

The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis

N Zhang, J Lei, Q Liu, W Huang, H Xiao, H Lei - Cardiology, 2015 - karger.com
Background: Coronary artery bypass grafting (CABG) is a key and effective surgical
treatment modality for coronary artery disease. Unfortunately, ischemia-reperfusion injury …

Function and mechanism of trimetazidine in myocardial infarction-induced myocardial energy metabolism disorder through the SIRT1–AMPK pathway

X Luo, Z Zhong, A Chong, W Zhang, X Wu - Frontiers in Physiology, 2021 - frontiersin.org
Myocardial energy metabolism (MEM) is an important factor of myocardial injury.
Trimetazidine (TMZ) provides protection against myocardial ischemia/reperfusion injury. The …

[HTML][HTML] Effects of trimetazidine on PDCD4/NF-κB/TNF-α pathway in coronary microembolization

Q Su, L Li, J Zhao, Y Sun, H Yang - Cellular Physiology and …, 2017 - karger.com
Background/Aims: The local inflammatory response caused by coronary microembolization
(CME) is the primary cause of progressive cardiac dysfunction. The PDCD4/NF-κB/TNF-α …

The protective effect of activating Nrf2/HO-1 signaling pathway on cardiomyocyte apoptosis after coronary microembolization in rats

J Liang, L Li, Y Sun, W He, X Wang, Q Su - BMC cardiovascular disorders, 2017 - Springer
Background Myocardial apoptosis is closely related to myocardial injury caused by coronary
microembolization (CME). Nuclear factor erythroid 2-like (Nrf2) has been taken into account …

[HTML][HTML] Puerarin pretreatment attenuates cardiomyocyte apoptosis induced by coronary microembolization in rats by activating the PI3K/Akt/GSK-3β signaling …

ZQ Chen, Y Zhou, JW Huang, F Chen… - Korean J Physiol …, 2021 - synapse.koreamed.org
Coronary microembolization (CME) is associated with cardiomyocyte apoptosis and cardiac
dysfunction. Puerarin confers protection against multiple cardiovascular diseases, but its …

Trimetazidine enhances myocardial angiogenesis in pressure overload-induced cardiac hypertrophy mice through directly activating Akt and promoting the binding of …

H Shu, Y Peng, W Hang, M Zhang, L Shen… - Acta Pharmacologica …, 2022 - nature.com
Latest clinical research shows that trimetazidine therapy during the perioperative period
relieves endothelial dysfunction in patients with unstable angina induced by percutaneous …